document.write('<link href=\"http://hosted2.ap.org/css/ComponentTypes/Headlines.css\" rel=\"Stylesheet\" type=\"text/css\" />');
document.write('');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
document.write('var localScriptObj = document.createElement(\"script\");localScriptObj.setAttribute(\"type\", \"text/javascript\");localScriptObj.setAttribute(\"charset\", \"utf-8\");localScriptObj.setAttribute(\"src\", \"http://hosted2.ap.org/scripts/dynamicScript.js\");var thisheadLoc = document.getElementsByTagName(\"head\").item(0);thisheadLoc.appendChild(localScriptObj);');
document.write('</script>');
document.write('');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
document.write('var localScriptObj = document.createElement(\"script\");localScriptObj.setAttribute(\"type\", \"text/javascript\");localScriptObj.setAttribute(\"charset\", \"utf-8\");localScriptObj.setAttribute(\"src\", \"http://hosted2.ap.org/scripts/cookies.js\");var thisheadLoc = document.getElementsByTagName(\"head\").item(0);thisheadLoc.appendChild(localScriptObj);');
document.write('</script>');
document.write('<link href=\"http://hosted2.ap.org/css/Hosted.css\" rel=\"Stylesheet\" type=\"text/css\" />');
document.write('<style type=\"text/css\">.apma5944e1668c54338a0db698adc9c7d76{}');
document.write('');
document.write('');
document.write('.hdl_combo-a5944e1668c54338a0db698adc9c7d76 .ap_hdr-a5944e1668c54338a0db698adc9c7d76 {display: block; }');
document.write('');
document.write('.hdl_combo-a5944e1668c54338a0db698adc9c7d76, .hdl_combo-a5944e1668c54338a0db698adc9c7d76 .ap_hdr-a5944e1668c54338a0db698adc9c7d76 {border-style: solid;border-width: 1px;border-color: #000000; }');
document.write('');
document.write('.hdl_combo .ap_hdr-a5944e1668c54338a0db698adc9c7d76 {background:none; background-color: #094fa3;line-height: 30px;font-family: Verdana;color: #FFFFFF;font-size: 14px;text-transform: capitalize;font-weight: bold;border-top: 0px; border-right: 0px; border-left: 0px; }');
document.write('');
document.write('.hdl_combo .ap_blk_hd-a5944e1668c54338a0db698adc9c7d76, .hdl_combo-a5944e1668c54338a0db698adc9c7d76 li a {font-family: Verdana;color: #556677;font-size: 12px;font-weight: bold;text-decoration: none; }');
document.write('');
document.write('.hdl_combo .ap_blk_hd_lrg-a5944e1668c54338a0db698adc9c7d76, .hdl_combo-a5944e1668c54338a0db698adc9c7d76 li a {font-family: Verdana;color: #094fa3;font-size: 14px;text-transform: none;font-weight: bold;text-decoration: none; }');
document.write('');
document.write('.hdl_combo-a5944e1668c54338a0db698adc9c7d76 li a:hover {color: #094FA3; }');
document.write('');
document.write('.hdl_combo .ap_dt_stmp-a5944e1668c54338a0db698adc9c7d76 {font-family: Verdana;color: #999999;font-size: 12px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_dt_stmp_lrg-a5944e1668c54338a0db698adc9c7d76 {font-family: Verdana;color: #999999;font-size: 11px;text-transform: none;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_tm_stmp-a5944e1668c54338a0db698adc9c7d76 {font-family: Verdana;color: #999999;font-size: 12px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_tm_stmp_lrg-a5944e1668c54338a0db698adc9c7d76 {font-family: Verdana;color: #999999;font-size: 11px;text-transform: none;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo .ap_aud_icn-a5944e1668c54338a0db698adc9c7d76 {background:url(http://hosted2.ap.org/images/audioIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_aud_icn-a5944e1668c54338a0db698adc9c7d76:hover {background:url(http://hosted2.ap.org/images/audioIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_vid_icn-a5944e1668c54338a0db698adc9c7d76 {background:url(http://hosted2.ap.org/images/videoIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_vid_icn-a5944e1668c54338a0db698adc9c7d76:hover {background:url(http://hosted2.ap.org/images/videoIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_pic_icn-a5944e1668c54338a0db698adc9c7d76 {background:url(http://hosted2.ap.org/images/photosIcon.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_pic_icn-a5944e1668c54338a0db698adc9c7d76:hover {background:url(http://hosted2.ap.org/images/photosIconHover.gif) left no-repeat; }');
document.write('');
document.write('.hdl_combo .ap_icn_ttl-a5944e1668c54338a0db698adc9c7d76 {font-family: Verdana;color: #094fa3;font-size: 12px;font-style: Normal; font-weight: normal;text-decoration: none;display: inline; }');
document.write('');
document.write('.hdl_combo .ap_icn_ttl-a5944e1668c54338a0db698adc9c7d76 a:hover {color: #094fa3; }');
document.write('');
document.write('.hdl_combo .ap_mlt_lnk-a5944e1668c54338a0db698adc9c7d76 {display: inline; }');
document.write('');
document.write('.hdl_combo .ap_slg_txt-a5944e1668c54338a0db698adc9c7d76 {font-family: Verdana;color: #000000;font-size: 12px;font-style: Normal; font-weight: normal; }');
document.write('');
document.write('.hdl_combo-a5944e1668c54338a0db698adc9c7d76 li {border-style: dotted;border-color: #ffffff;border-width: 10px; border-top: 0px; border-right: 0px; border-left: 0px;clear: both; padding: 5px 3px 3px 0px; margin: 0px; list-style: none; }');
document.write('');
document.write('.hdl_combo .ap_mdl_frm-a5944e1668c54338a0db698adc9c7d76 {padding:0px 0px 0px 5px; }');
document.write('');
document.write('.hdl_combo .ap_cnt_area-a5944e1668c54338a0db698adc9c7d76 {padding-left: 0px;background-color: #FFFFFF; display:inline-block; }');
document.write('');
document.write('.hdl_combo .ap_blt_on-a5944e1668c54338a0db698adc9c7d76 li {list-style: url(http://hosted2.ap.org/images/bult.gif); }');
document.write('');
document.write('.hdl_combo .ap_li_end-a5944e1668c54338a0db698adc9c7d76 {padding-bottom: 0px; }');
document.write('');
document.write('');
document.write('');
document.write('</style></head><body>');
document.write('<script type=\"text/javascript\" language=\"javascript\">');
eval("var updateHeadlines096e4711502f48ee82fc64b038e27899 = function() { dynamicRefresh('http://hosted2.ap.org/json/WORAM/a5944e1668c54338a0db698adc9c7d76/uid-096e4711502f48ee82fc64b038e27899', 900000, '', '096e4711502f48ee82fc64b038e27899'); }");
document.write('');
eval("setTimeout('updateHeadlines096e4711502f48ee82fc64b038e27899()', 900000);");
document.write('</script>');
document.write('<div id=\"divhdl_comboc55e9697aad54086b7a153262a72fe37\">');
document.write('');
document.write('<div class=\"hdl_combo hdl_combo-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<div class=\"ap_hdr ap_hdr-a5944e1668c54338a0db698adc9c7d76\" style=\"width:100%; display:block\">Drug Regulation in the News</div>');
document.write('');
document.write('<ul class=\"ap_cnt_area ap_cnt_area-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-a5944e1668c54338a0db698adc9c7d76\" href=\"http://hosted2.ap.org/WORAM/a5944e1668c54338a0db698adc9c7d76/Article_2010-02-09-US-Radiation-Scans-FDA/id-pebc7261789a942ab94d0f037d06a0b76\">FDA aims to rein in radiation-based medical scans</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\">9 Feb. 2010</span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-a5944e1668c54338a0db698adc9c7d76\">WASHINGTON (AP) — Federal regulators will require manufacturers of high-grade medical imaging machines to include safety controls that prevent patients from receiving excessive radiation doses.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-a5944e1668c54338a0db698adc9c7d76\" href=\"http://hosted2.ap.org/WORAM/a5944e1668c54338a0db698adc9c7d76/Article_2010-02-09-US-Radiation-Scans-FDA-Glance/id-p6a45e257656341a0b016e223af1845fc\">Glance: Rising radiation exposure tied to imaging</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\">9 Feb. 2010</span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-a5944e1668c54338a0db698adc9c7d76\">The Food and Drug Administration said Tuesday it will work with doctors and manufacturers to reduce unnecessary radiation exposure from medical scans, a problem that has been growing for decades.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-a5944e1668c54338a0db698adc9c7d76\" href=\"http://hosted2.ap.org/WORAM/a5944e1668c54338a0db698adc9c7d76/Article_2010-02-09-US-Amgen-Study/id-pbdb3aafe48a944c687c7a2cb0b6371e4\">Amgen sees positive data in bone drug study</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\">9 Feb. 2010</span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-a5944e1668c54338a0db698adc9c7d76\">THOUSAND OAKS, Calif. (AP) — Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li>');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-a5944e1668c54338a0db698adc9c7d76\" href=\"http://hosted2.ap.org/WORAM/a5944e1668c54338a0db698adc9c7d76/Article_2010-02-08-US-Crestor-Expanded-Approval/id-p749cdc6f43ea4518a7ec054e9d220538\">AstraZeneca gets OK for expanded Crestor use</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\">8 Feb. 2010</span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-a5944e1668c54338a0db698adc9c7d76\">WASHINGTON (AP) — Federal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('<li class=\"ap_li_end ap_li_end-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<div class=\"ap_mdl_frm ap_mdl_frm-a5944e1668c54338a0db698adc9c7d76\">');
document.write('');
document.write('<a class=\"ap_blk_hd ap_blk_hd_lrg-a5944e1668c54338a0db698adc9c7d76\" href=\"http://hosted2.ap.org/WORAM/a5944e1668c54338a0db698adc9c7d76/Article_2010-02-08-US-Becton-Dickinson-Recall/id-p0c438722aeaf4894b848532cbb1c6040\">Becton Dickinson expands catheter product recall</a>');
document.write('');
document.write('<p class=\"ap_dt_tm\">');
document.write('');
document.write('<span class=\"ap_dt_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\">8 Feb. 2010</span>');
document.write('');
document.write('<span class=\"ap_tm_stmp_lrg-a5944e1668c54338a0db698adc9c7d76\"></span>');
document.write('');
document.write('</p>');
document.write('');
document.write('<p class=\"ap_slg_txt ap_slg_txt-a5944e1668c54338a0db698adc9c7d76\">FRANKLIN LAKES, N.J. (AP) — Medical products company Becton Dickinson and Co. said Monday it expanding a recall for catheter devices because a manufacturing problem could cause potentially fatal embolisms or blood leakage.</p>');
document.write('');
document.write('<div class=\"ap_bl_div\">&nbsp;</div>');
document.write('');
document.write('</div>');
document.write('');
document.write('</li>');
document.write('');
document.write('</ul>');
document.write('');
document.write('</div>');
document.write('');
document.write('</div>');
document.write('</body></html>');